Presentation

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Presenter: Marco Ferlini

February 13, 2020

REGISTER for free or LOG IN to view this content

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Coronary

ACS/AMI

Presentation

JIM 2020

Antiplatelet Therapy

STEMI

NSTEMI

Up Next

Presentation

Technical innovations in CTO

Presenter: Mauro Carlino

February 13, 2020

More slides +

Presentation

PCI in a NSTEMI patient When less is more…

Presenter: Baralis Giorgio

February 13, 2020

Presentation

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presenter: Marco Valgimigli

February 13, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.